Actinium Pharmaceuticals Inc Financial Flexibility Index
Actinium Pharmaceuticals Inc financial flexibility index. Actinium Pharmaceuticals Inc (ATNM) has a Financial Flexibility Index of -0.14x as of March 2026. Free cash flow of $-5.87 Million (operating CF $-5.87 Million minus capex $2.00K) represents 0% of total liabilities ($43.13 Million). Explore Actinium Pharmaceuticals Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Actinium Pharmaceuticals Inc (2006–2025)
Financial flexibility index of Actinium Pharmaceuticals Inc from 2006 to 2025. Historical Financial Flexibility Index trend for Actinium Pharmaceuticals Inc across 20 annual periods. Check cash flow reinvestment rate of Actinium Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
Actinium Pharmaceuticals Inc Financial Flexibility Index by Year (2006–2025)
Actinium Pharmaceuticals Inc financial flexibility index by year from 2006 to 2025. Year-by-year free cash flow to debt coverage for Actinium Pharmaceuticals Inc. For the full cash flow conversion analysis, see Actinium Pharmaceuticals Inc cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.56x | $-24.48 Million | $-24.58 Million | $43.94 Million | ▲ +25.6% |
| 2024 | -0.75x | $-33.06 Million | $-33.07 Million | $44.14 Million | ▲ +28.5% |
| 2023 | -1.05x | $-47.18 Million | $-47.34 Million | $45.07 Million | ▼ -654.4% |
| 2022 | 0.19x | $9.01 Million | $8.64 Million | $47.71 Million | ▲ +106.2% |
| 2021 | -3.03x | $-20.73 Million | $-20.87 Million | $6.84 Million | ▲ +28.0% |
| 2020 | -4.21x | $-21.36 Million | $-21.62 Million | $5.08 Million | ▼ -18.5% |
| 2019 | -3.55x | $-21.40 Million | $-21.46 Million | $6.03 Million | ▼ -5.4% |
| 2018 | -3.37x | $-20.47 Million | $-20.57 Million | $6.08 Million | ▲ +27.0% |
| 2017 | -4.61x | $-21.53 Million | $-21.55 Million | $4.67 Million | ▼ -0.6% |
| 2016 | -4.59x | $-20.73 Million | $-20.79 Million | $4.52 Million | ▼ -14.4% |
| 2015 | -4.01x | $-18.50 Million | $-18.54 Million | $4.61 Million | ▼ -168.0% |
| 2014 | -1.50x | $-14.20 Million | $-14.35 Million | $9.49 Million | ▼ -74.6% |
| 2013 | -0.86x | $-6.28 Million | $-6.29 Million | $7.33 Million | ▲ +23.7% |
| 2012 | -1.12x | $-5.21 Million | $-5.21 Million | $4.64 Million | ▼ -17687.8% |
| 2011 | 0.01x | $539.00 | $539.00 | $84.48K | ▼ -92.3% |
| 2010 | 0.08x | $7.83K | $7.83K | $94.77K | ▲ +143.3% |
| 2009 | -0.19x | $-18.78K | $-18.78K | $98.41K | ▼ -4.1% |
| 2008 | -0.18x | $-13.96K | $-13.96K | $76.18K | ▲ +53.1% |
| 2007 | -0.39x | $-15.49K | $-15.49K | $39.64K | ▲ +47.4% |
| 2006 | -0.74x | $-14.03K | $-14.03K | $18.87K | — |